Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Complications and adverse events during follow-up period after dual therapy with anti-VEGF and dexamethasone intravitreal implant.
| Complications and adverse events (n=18) | ||
|---|---|---|
| N | percentage | |
| IOP elevations | 2 | 11.11% |
| Glaucoma drops | 2 | 11.11% |
| Glaucoma surgery | 0 | 0.00% |
| Pre-existing cataract worsening | 1 | 5.56% |
| New cataract formation | 0 | 0.00% |
| Cataract surgery | 1 | 5.56% |
| Vitreous hemorrhage | 0 | 0.00% |
| Anterior migration of implant | 0 | 0.00% |
| Endophthalmitis | 0 | 0.00% |
